Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 1334Neoplasms 1111Carcinoma, Non-Small-Cell Lung 923Prostatic Neoplasms 755Colorectal Neoplasms 653Lung Neoplasms 626Neoplasm Metastasis 476Multiple Myeloma 449Leukemia, Myeloid, Acute 441Pancreatic Neoplasms 394Ovarian Neoplasms 390Melanoma 350Carcinoma, Hepatocellular 311Brain Neoplasms 293Recurrence 289Squamous Cell Carcinoma of Head and Neck 287Glioblastoma 263Head and Neck Neoplasms 256Stomach Neoplasms 255Precursor Cell Lymphoblastic Leukemia-Lymphoma 242Carcinoma, Renal Cell 241Lymphoma 237Triple Negative Breast Neoplasms 234Endometrial Neoplasms 223Hematologic Neoplasms 220Uterine Cervical Neoplasms 217Urinary Bladder Neoplasms 213Glioma 208Lymphoma, Non-Hodgkin 206Sarcoma 204

Interventions

enasidenib 1dehydroftorafur 1Radiotherapy 1Radiation 1Platinum 1Fluorouracil 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × 90 days × Clear all
NCT06176989 2026-06-03

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
40 enrolled
CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06814496 2026-05-20

RABBIT

University of Arizona

Phase 1/2 Recruiting
30 enrolled
CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡